Perslev, Kathrine
Klarskov, Niels
Bergholt, Thomas
Jangö, Hanna https://orcid.org/0000-0003-0224-1425
Funding for this research was provided by:
Herlev Hospital
Copenhagen University
Article History
Received: 7 August 2023
Accepted: 20 March 2024
First Online: 27 March 2024
Declarations
:
: This study has been approved through the new European CTIS, where it has been approved by both the scientific ethics committee in Denmark and the Danish Medicines Agency (see Additional file ). Written, informed consent to participate will be obtained from all participants. The primary investigator will update the rest of the research group on a daily to weekly basis depending on the situation. The study will further be monitored by the GCP unit and reported to the region’s data registration system Pactius. Any important changes to the protocol will be reported to the GCP-unit and CTIS for approval.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests.